Significantly, genetic or pharmacological inhibition of CaMKK2 protected hippocampal neurons from the synaptotoxic effects of Aβ42 both in vitro, and in the human APPSWD/IND transgenic mouse model of Alzheimer’s disease [6]. This evidence concerns the gene CAMKK2 and early-onset autosomal dominant Alzheimer disease.